Thea Bätz provides an overview of systemic treatment options for patients with advanced hepatocellular carcinoma (HCC)
Thea Bätz provides an overview of systemic treatment options for patients with advanced hepatocellular carcinoma (HCC)
Thea Bätz works as study coordinator in the outpatient department for hepatocellular carcinomas at the Johannes Gutenberg University in Mainz. In this function, she cares for study patients and outpatients. After completing her training, she worked for 18 years as a children’s nurse at the University Hospital in Lübeck. Since 2000 Thea Bätz has been working at the University Medical Center Mainz, where she first worked in cardiology and GI oncology. She completed her training as a study assistant and has been working in the HCC area since the SHARP Trial. Due to the close cooperation within the study office she is also involved in the GI oncology area. In recent years, she has participated in several projects on practical work with oncological patients, taking into consideration international differences.
Survey findings presented at ONS 2025 and published in the journal Healthcare
Paola Belardi RN reviews key abstracts from EONS15 at ESMO 2022.
Beth Wittmer RN is joined by Prof. Hans Prenen from GI CONNECT in this podcast on the management of dermatological side effects that patients may experience when receiving treatment with multikinase inhibitors (MKIs)
Nurse Practitioner Natasha Pinheiro discusses the increasing prevalence of of young-onset colorectal cancer from the nurse's perspective. Watch the video and download the slides.
Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers